Literature DB >> 22623778

Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.

Aaron W Lifland1, Jeenah Jung, Eric Alonas, Chiara Zurla, James E Crowe, Philip J Santangelo.   

Abstract

Currently, the spatial distribution of human respiratory syncytial virus (hRSV) proteins and RNAs in infected cells is still under investigation, with many unanswered questions regarding the interaction of virus-induced structures and the innate immune system. Very few studies of hRSV have used subcellular imaging as a means to explore the changes in localization of retinoic-acid-inducible gene-I (RIG-I)-like receptors or the mitochondrial antiviral signaling (MAVS) protein, in response to the infection and formation of viral structures. In this investigation, we found that both RIG-I and melanoma differentiation-associated gene 5 (MDA5) colocalized with viral genomic RNA and the nucleoprotein (N) as early as 6 h postinfection (hpi). By 12 hpi, MDA5 and MAVS were observed within large viral inclusion bodies (IB). We used a proximity ligation assay (PLA) and determined that the N protein was in close proximity to MDA5 and MAVS in IBs throughout the course of the infection. Similar results were found with the transient coexpression of N and the phosphoprotein (P). Additionally, we demonstrated that the localization of MDA5 and MAVS in IBs inhibited the expression of interferon β mRNA 27-fold following Newcastle disease virus infection. From these data, we concluded that the N likely interacts with MDA5, is in close proximity to MAVS, and localizes these molecules within IBs in order to attenuate the interferon response. To our knowledge, this is the first report of a specific function for hRSV IBs and of the hRSV N protein as a modulator of the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22623778      PMCID: PMC3421640          DOI: 10.1128/JVI.00215-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Ultrastructural studies of the multiplication of RS (respiratory syncytial) virus.

Authors:  E Norrby; H Marusyk; C Orvell
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

2.  Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein.

Authors:  Reena Ghildyal; Dongsheng Li; Irene Peroulis; Benjamin Shields; Phillip G Bardin; Michael N Teng; Peter L Collins; Jayesh Meanger; John Mills
Journal:  J Gen Virol       Date:  2005-07       Impact factor: 3.891

3.  Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions.

Authors:  B García-Barreno; T Delgado; J A Melero
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

4.  Role for innate IFNs in determining respiratory syncytial virus immunopathology.

Authors:  Teresa R Johnson; Sara E Mertz; Negin Gitiban; Sue Hammond; Robin Legallo; Russell K Durbin; Joan E Durbin
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

5.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

6.  Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.

Authors:  Ping Liu; Mohammad Jamaluddin; Kui Li; Roberto P Garofalo; Antonella Casola; Allan R Brasier
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

7.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

8.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

9.  Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein.

Authors:  J García; B García-Barreno; A Vivo; J A Melero
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

10.  Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells.

Authors:  S R Roberts; R W Compans; G W Wertz
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more
  83 in total

1.  The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism.

Authors:  Pradyumna S Baviskar; Anne L Hotard; Martin L Moore; Antonius G P Oomens
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

Review 2.  Using Large Datasets to Understand Nanotechnology.

Authors:  Kalina Paunovska; David Loughrey; Cory D Sago; Robert Langer; James E Dahlman
Journal:  Adv Mater       Date:  2019-08-20       Impact factor: 30.849

3.  Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.

Authors:  Tsuyoshi Miyake; Charlotte M Farley; Benjamin E Neubauer; Thomas P Beddow; Thomas Hoenen; Daniel A Engel
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

4.  Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective.

Authors:  Nico Marr; Stuart E Turvey; Nathalie Grandvaux
Journal:  Trends Microbiol       Date:  2013-10-09       Impact factor: 17.079

5.  Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2.

Authors:  Jingjing Pei; Nicole D Wagner; Angela J Zou; Srirupa Chatterjee; Dominika Borek; Aidan R Cole; Preston J Kim; Christopher F Basler; Zbyszek Otwinowski; Michael L Gross; Gaya K Amarasinghe; Daisy W Leung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

6.  A Novel Method to Quantify RNA-Protein Interactions In Situ Using FMTRIP and Proximity Ligation.

Authors:  C Zurla; J Jung; E L Blanchard; P J Santangelo
Journal:  Methods Mol Biol       Date:  2017

7.  Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5.

Authors:  Nathalie Grandvaux; Xiaochun Guan; Fabrice Yoboua; Nicolas Zucchini; Karin Fink; Priscilla Doyon; Lydie Martin; Marc J Servant; Stéfany Chartier
Journal:  J Innate Immun       Date:  2014-04-30       Impact factor: 7.349

8.  p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly.

Authors:  Jens Fricke; Lily Y Koo; Charles R Brown; Peter L Collins
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Authors:  Peter L Collins; Rachel Fearns; Barney S Graham
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.

Authors:  J Tyler Kinder; Carole L Moncman; Chelsea Barrett; Hong Jin; Nicole Kallewaard; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.